Structure, Function and Expression of the Human Calcitonin/α-CGRP Gene

  • Ian Marshall
  • Susan Al-Kazwini
  • Jenny J. Holman
  • Peter M. Broad
  • Mark R. Edbrooke
  • Roger K. Craig
Part of the Biochemical Endocrinology book series (BIOEND)


Calcitonin is a small peptide hormone (32 amino acids) synthesised and secreted in mammals by the C-cells of the thyroid (Foster et al., 1964). The physiological role of calcitonin in mammals appears to be the protection of the skeleton in times of calcium stress such as growth, pregnancy and lactation (Stevenson et al., 1979). In common with other small peptide hormones, molecular cloning and nucleotide sequence analysis of rat and human calcitonin mRNA (Atnara et al., 1982; Craig et al., 1982; Le Moullec et al., 1984) demonstrates that calcitonin mRNA encodes a precursor polyprotein. Within this precursor, calcitonin is flanked by amino and carboxy terminal peptides of as yet unknown function, from which calcitonin is proteolytically cleaved and amidated prior to secretion (see Craig et al., 1982). The human calcitonin gene is expressed at elevated levels ectopically in lung carcinoma (Coombes et al., 1974), and at grossly elevated levels in medullary thyroid carcinoma (Milhaud et al., 1974). Elegant studies on the structure and expression of the rat calcitonin gene have resulted in renewed interest in this gene. These demonstrate the generation by RNA processing of alternative mRNA species from a single gene in an apparently tissue-specific manner. The mRNAs encode polyproteins cleaved by post-translational events to yield either calcitonin or the calcitonin gene-related peptide (CGRP) (Amara et al., 1982). Subsequent immunocyto-chemical studies showed a wide distribution of rat CGRP-producing cells within discrete regions of the central and peripheral nervous system (Rosenfeld et al., 1983). This suggests a potential role as a neuromodulator or neurotransmitter molecule, a supposition which has led to detailed analyses in a number of laboratories of the structure, function and expression of rat and human calcitonin/CGRP gene(s).


Medullary Thyroid Carcinoma Salmon Calcitonin CGRP Receptor Human Calcitonin Mesenteric Vasculature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Al-Kazwini, S.J., Craig, R.K., Holman, J.J. and Marshall, I. (1985). Human and rat calcitonin gene-related peptides are vasodilators in coronary and mesenteric vasculature. Br. J. Pharmac., Proc. Suppl., in press.Google Scholar
  2. Amara, S.G., Jonas, V., Rosenfeld, M.G., Ong, E.S., and Evans, R.M. (1982). Alternative RNA processing in calcitonin gene expression: mRNAs encoding different polypeptide products. Nature, 298:240–244.PubMedCrossRefGoogle Scholar
  3. Bates, R.F.L., Buckley, G.A. and McArdle, C.A. (1984). Comparison of the antinociceptive effects of centrally administered calcitonin and calcitonin gene-related peptide. Br. J. Pharmac., 82:295.Google Scholar
  4. Birnstiel, M.L., Busslinger, M. and Strub, K. (1985). Transcription termination and 3′ processing: the end is in site. Cell, 41:349–359.PubMedCrossRefGoogle Scholar
  5. Brain, S.D., Williams, T.J., Tippins, J.R., Morris, H.R. and MacIntyre, I. (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature, 313:54–56.PubMedCrossRefGoogle Scholar
  6. Cauvin, C., Loutzenhiser, R. and van Breemen, C. (1983). Mechanisms of calcium antagonist induced vasodilation. Annu. Rev. Pharmacol., 23:373–396.CrossRefGoogle Scholar
  7. Coombes, R.C., Greenberg, P.B., Hillyard, C. and MacIntyre, I. (1974). Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet, i:1080–1083.CrossRefGoogle Scholar
  8. Craig, R.K., Hall, L., Edbrooke, M.R., Allison, J. and MacIntyre, I. (1982). Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature, 295:345–347.PubMedCrossRefGoogle Scholar
  9. Craig, R.K., Edbrooke, M.R., Riley, J.H., McVey, J.H. and Parker, D. (1985). Differential expression of the human calcitonin/CGRP gene in medullary thyroid carcinoma and lung carcinoma cell-lines. Recent Results in Cancer Research, 99:71–78.PubMedGoogle Scholar
  10. Craig, R.K., Marshall, I., Paciorek, P. & Shepperson, N.B. (1986). Cardiovascular effects of human and rat calcitonin gene-related peptides in anaesthetised dog. Br. J. Pharmac., Proc. Suppl.Google Scholar
  11. Edbrooke, M.R., Parker, D., McVey, J.H., Riley, J.H., Sorenson, G.D., Pettengill, O.S. and Craig, R.K. (1985). Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma. EMBO J., 4:715–724.PubMedGoogle Scholar
  12. Fisher, L.A., Kikkawa, D.O., Rivier, J.E., Amara, S.G., Evans, R.M., Rosenfeld, M.G., Vale, W.W. and Brown, M.R. (1983). Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature, 305:534–536.PubMedCrossRefGoogle Scholar
  13. Foster, G.V., Baghdiantz, A., Kunar, M.A., Slack, E., Soliman, H.A. and MacIntyre, I. (1964). Thyroid origin of calcitonin. Nature, 202:1303–1305.PubMedCrossRefGoogle Scholar
  14. Furchgott, R.F., Cherry, P.D., Zawadzki, J.V. & Jothianandan, D. (1984). Endothelial cells as mediators of vasodilation of arteries. J. Cardiovascular Pharm., 6:S336–S343.CrossRefGoogle Scholar
  15. Girgis, S.I., MacDonall, D.W., Stevenson, J.C., Bevis, P.J.R., Lynch, C., Wimalawansa, J.S., Self, C.H., Morris, H.R. & MacIntyre I. (1985). Calctonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet ii:14–16.CrossRefGoogle Scholar
  16. Goltzman, D. & Mitchell, J. (1985). Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science, 227:1343–1345PubMedCrossRefGoogle Scholar
  17. Goth, A. (1973). Histamine released by drugs and chemicals. In Histamine and antihistamines ed. Schachter, M. Vol. I Int. Encyclopedia of Pharmacology and Therapeutics, section 74, Pergamon Press, London, p25.Google Scholar
  18. Hughes, J.J., Levine, A.S., Morely, J.E., Gosnell, B.A. & Silivis, S.E. (1984). Intraventricular calcitonin gene-related peptide inhibits gastric acid secretion. Peptides 5:665.PubMedCrossRefGoogle Scholar
  19. Jonas, V., Lin, C.R., Kawashima, E., Semon, D., Swanson, L.W., Mermod, J.-J., Evans, R.M. and Rosenfeld, M.G. (1985). Alternative RNA processing events in human calcitonin/CGRP gene expression. Proc. Natl. Acad. Sci. U.S.A. 82: 1994–1998.PubMedCrossRefGoogle Scholar
  20. Le Moullec, J.M., Jullienne, A., Chenais, J., Lasmoles, F., Guliana, J.M., Milhaud, G. and Moukhtar, M.S. (1984). The complete sequence of human preprocalcitonin. FEBS Lett. 167: 93–97.PubMedCrossRefGoogle Scholar
  21. Mather, E.L., Nelson, K.J., Haimovich, J. and Perry, R.P. (1984). Mode of regulation of immunoglobulin μ and δ chain expression varies during B-lymphocyte maturation. Cell, 36:329–338.PubMedCrossRefGoogle Scholar
  22. Milhaud, G., Calmette, C., Taboulet, J., Julienne, A. and Moukhtar, M.S. (1974). Hypersecretion of calcitonin in neoplastic conditions. Lancet, i 462–463.CrossRefGoogle Scholar
  23. Morales-Aguilera, A. & Vaughan-Williams, E.M. (1965). The effects on cardiac muscle of β-receptor antagonists in relation to their activity as local anaesthetics. Br. J. Pharmac., 24:332.Google Scholar
  24. Morris, H.R., Panico, M., Etienne, T., Tippins, J., Girgis, S.I. and MacIntyre, I. (1984). Isolation and characterisation of human calcitonin gene-related peptide. Nature, 308:746–748.PubMedCrossRefGoogle Scholar
  25. Mulderry, P.K., Ghatel, M.A., Rodrigo, J., Allen, J.M., Rosenfeld, M.G., Polak, J.M. and Bloom, S.R. (1985). Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience, 14:947–954.PubMedCrossRefGoogle Scholar
  26. Nelkin, B.D., Rosenfeld, K.I., de Bustros, A., Leong, S.S., Roos, B.A. and Baylin, S.B. (1984). Structure and expression of a gene encoding human calcitonin and calcitonin gene-related peptide. Biochem. Biophys. Res. Comun., 123:648–655.CrossRefGoogle Scholar
  27. Rosenfeld, M.G., Mermod, J-J., Amara, S.G., Swanson, L.W., Sawchenko, P.E., Rivier, J., Vale, W.W. and Evans, R.M. (1983). Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature, 304:129–135.PubMedCrossRefGoogle Scholar
  28. Rosenfeld, M.G., Amara, S.G. and Evans, R.M. (1984). Alternative RNA processing: determining neuronal phenotype. Science, 225:1315–1320.PubMedCrossRefGoogle Scholar
  29. Steenbergh, P.H., Höppener, J.W.M., Zandberg, J., Van de Ven, W.J.M., Jansz, H.S. and Lips, C.J., (1984). Calcitonin gene-related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma. J. Clin. Endocrinol. Metab., 59:358–360.PubMedCrossRefGoogle Scholar
  30. Stevenson, J.C., Hillyard, L.J., MacIntyre, I., Cooper, M. and Whitehead, M.I. (1979). A physiological role for calcitonin: protection of the maternal skeleton. Lancet, ii 769–770.CrossRefGoogle Scholar
  31. Tache, Y., Pappas, T., Lauffenburger, M., Goto, Y., Walsh, J.H. & Debas, H. (1984). Calcitonin gene-related peptide: potent peripheral inhibitor of gastric acid secretion in rats and dogs. Gastroenterology, 87:344.PubMedGoogle Scholar
  32. Tippins, J.R., Morris, H.R., Panico, M., Etienne, T., Bevis, P., Girgis, S., MacIntyre, I., Azria, M. & Attinger, M. (1984). The myotropic and plasma calcium modulating effects of calcitonin gene-related peptide. Neuropeptides, 4: 425.PubMedCrossRefGoogle Scholar
  33. Tschopp, F.A., Henke, H., Petermann, J.B., Tobler, P.H., Janzer, R., Hokfelt, T., Lundberg, J.M., Cuello, C. & Fischer, J.A. (1985). Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc. Natl. Acad. Sci. U.S.A., 82:248.PubMedCrossRefGoogle Scholar
  34. Williams, F.D., Ponder, B.A.J. and Craig, R.K. (1986). CGRP in human medullary carcinoma and C-cell hyperplasia — an immunohistochemical study. Clin. Endocrinol. submitted.Google Scholar
  35. Winquist, R.J., Faison, E.P. & Nutt, R.F. (1984). Vasodilator profile of synthetic atrial natriuretic factor. Eur. J. Pharmac., 102:169–173.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Ian Marshall
    • 1
  • Susan Al-Kazwini
    • 1
  • Jenny J. Holman
    • 1
  • Peter M. Broad
    • 2
  • Mark R. Edbrooke
    • 2
  • Roger K. Craig
    • 2
  1. 1.Department of Pharmacology and TherapeuticsThe Middlesex Hospital Medical SchoolLondonUK
  2. 2.Cancer Research Campaign Endocrine Tumour Molecular Biology Group Courtauld Institute of BiochemistryThe Middlesex Hospital Medical SchoolLondonUK

Personalised recommendations